IPR2016-01018 (Coherus BioSciences Inc.) (U.S. Patent No. 9,114,166)
- Petitioner: Coherus BioSciences Inc.
- Patent: U.S. Patent No. 9,114,166
- Title: Formulation of human antibodies for treating TNF-α associated disorders
- Related Product: HUMIRA®
- Patent Owner: AbbVie Biotechnology Ltd.
Related Content
- Big Molecule WatchMay 15, 2024
Amgen and Sandoz Settle Denosumab BPCIA Litigation
- Big Molecule WatchMay 14, 2024
Alexion’s Preliminary Injunction Motion Denied in Eculizumab BPCIA Litigation Against Samsung Bioepis
- Big Molecule WatchMay 10, 2024
Court Cancels Injunction Hearings In Aflibercept BPCIA Litigation; Regeneron May Seek Temporary Restraining Orders
- Big Molecule WatchMay 9, 2024
IRA Litigation Updates: D.N.J. Rejects Challenges from BMS and Janssen; Four Cases Now on Appeal
- Big Molecule WatchMay 3, 2024
FDA Updates Draft Guidance on Promotional Communications of Prescription Biologics and Biosimilars
- Big Molecule WatchMay 2, 2024
Accord BioPharma, Inc. Announces FDA Approval of HERCESSI (trastuzumab-strf)
- Big Molecule WatchMay 1, 2024
PTAB Issues Final Written Decisions Finding Claims of Recombinant Lentiviral Vector Patents Valid
- Big Molecule WatchApril 30, 2024
Biosimilar Approval Updates in Europe and China
- Awards and RankingsSeptember 25, 2023
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Twelfth Consecutive Year
- Awards and RankingsOctober 4, 2022
LMG Recognizes Goodwin Lawyers and Practices for Excellence in Life Sciences
- Press ReleaseNovember 17, 2021
Goodwin Releases Update to its Comprehensive Guide to Biosimilars Litigation and Regulation in the U.S.
- Awards and RankingsOctober 26, 2021
Goodwin Named an LMG Life Sciences Life Cycle Firm for the Tenth Consecutive Year
- Press ReleaseJune 28, 2021
Goodwin Adds Life Sciences and Healthcare Litigation Partner William Jackson
- EventsDecember 5, 2020
China's Patent Linkage System: Can Strategies that Work in the U.S. System Be Applied to China?
- Awards and RankingsOctober 5, 2020
Goodwin Named An LMG Life Sciences Life Cycle Firm For The Ninth Consecutive Year
- Speaking EngagementsSeptember 23, 2020
ACI's 11th Summit on Biosimilars & Innovator Biologics